Effect of decreased plasma cholesterol by atorvastatin treatment on erythrocyte mechanical properties

Clinical Hemorheology and Microcirculation

Volumn 36, Issue 1, 2007, Pages 25-33

  Uyuklu, Mehmet ^a   Meiselman, Herbert J ^b   Baskurt, Oguz K ^a  

^a AKDENIZ UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Atorvastatin; Cholesterol; Erythrocyte deformability; Erythrocyte membrane

Indexed keywords

3 HYDROXY 3 METHYLGLUTARYL COENZYME A; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ATORVASTATIN; CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHOLIPID; TRIACYLGLYCEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROCYTE; ERYTHROCYTE DEFORMABILITY; ERYTHROCYTE MEMBRANE; ERYTHROCYTE SHAPE; GUINEA PIG; HYPOCHOLESTEROLEMIA; MALE; NONHUMAN; PHOSPHOLIPID BLOOD LEVEL; STATISTICAL SIGNIFICANCE;

ALANINE TRANSAMINASE; ANIMALS; ANTICHOLESTEREMIC AGENTS; ASPARTATE AMINOTRANSFERASES; CHOLESTEROL; ERYTHROCYTE DEFORMABILITY; ERYTHROCYTE INDICES; ERYTHROCYTE MEMBRANE; GUINEA PIGS; HEPTANOIC ACIDS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LIPIDS; LIPOPROTEINS; MALE; MEMBRANE LIPIDS; NA(+)-K(+)-EXCHANGING ATPASE; PHOSPHOLIPIDS; PYRROLES;

EID: 33846084595     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. C.C. Allain, L.S. Poon, C.S. Chan and W.F.P.C. Richmond, Enzymatic determination of total serum cholesterol, Clin. Chem. 20 (1974), 470-475.
2. O.K. Baskurt and H.J. Meiselman, Analyzing shear stress-elongation index curves: comparison of two approaches to simplify data presentation, Clin. Hemorheol. Microcirc. 31 (2004), 23-30.
3. J.D. Baure, Laboratory investigation of hemoglobin, in: Gradwohl's Clinical Laboratory Methods and Diagnosis, A.C. Sonnenwirth and L. Jarelt, eds, Mosby, St. Louis, 1980, pp. 809-902.
4. J.D. Baure and P.G. Ackerman, Clinical Laboratory Methods, Mosby, St. Louis, 1974.
5. H.U. Bergmeyer, M. Horder and R. Rej, International Federation of Clinical Chemistry (IFCC) scientific committee, analytical section: approved recommendations (1985) on IFCC methods for the measurement of catalytic concentrations of enzymes. Part 2. IFCC method for aspartate aminotransferase (L-aspartate: 2-oxoglutarate aminotransferase, EC 2.6.1.1), J. Clin. Chem. Biochem. 24 (1986), 497-510.
6. H.U. Bergmeyer, M. Horder and R. Rej, International Federation of Clinical Chemistry (IFCC) scientific committee, analytical section: approved recommendations (1985) on IFCC methods for the measurement of catalytic concentrations of enzymes. Part 3. IFCC method for alanine aminotransferase (L-alanine: 2-oxoglutarate aminotransferase, EC 2.6.1.2), J. Clin. Chem. Biochem. 24 (1986), 481-495.
7. C.L. Bisgaier, A.D. Essenburg, B.J. Auerbach, M.E. Pape, C.S. Sekerke, S. Gee and R.S. Newton, Attenuation of plasma low density lipoprotein cholesterol by slect 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in mice devoid of low density lipoprotein receptors, J. Lipid. Res. 38 (1998), 2502-2515.
8. M.M. Carreiras, T. Proverbio, F. Proverbio and R. Marin, Preeclampsia and Na,K-ATPase activity of red blood cell ghosts from neonatal and maternal blood, Biol. Neonate 79 (2001), 5-8.
9. S. Chien, Red cell deformability and its relevance to blood flow, Ann. Rev. Physiol. 49 (1987), 177-192.
10. J.I. Cleeman, S.M. Grundy, D. Becker, L.T. Clark, R.S. Cooper, M.A. Denke, W.J. Howard, D.B. Hunninghake, D.R. Illingworth, R.V. Luepker, P. McBride, J.M. McKenney, R.C. Pasternak, N.J. Stone, L. Van Horn, H.B. Brewer, N.D. Ernst, D. Gordon, D. Levy, B. Rifkind, J.E. Rossouw, P. Savage, S.M. Haffner, D.G. Orloff,M.A. Proschan, J.S. Schwartz, C.T. Sempos, S.T. Shero and E.Z. Murray, Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III), JAMA 285 (2001), 2486-2497.
11. K. Conde, M. Vergara-Jimenez, B.R. Krause, R.S. Newton and M.L. Fernandez, Hypercholesterolemic actions of atorvastatin are associated with alterations of hepatic cholesterol metabolism and lipoprotein composition in guinea pig, J. Lipid. Res. 37 (1996), 2372-2382.
12. R.A. Cooper, Abnormalities of cell membrane fluidity in the pathogenesis of disease, N. Engl. J. Med. 297 (1977), 371-377.
13. B. Engelmann, J. Duhm, U.M. Schonthier and S. Streich, Relations of sodium-lithium countertransport kinetics to plasma and red cell membrane phospholipids in hyperlipidemia, Atherosclerosis 99 (1993), 151-163.
14. M.L. Fernandez, Guinea pig as models for cholesterol and lipoprotein metabolism, J. Nutr. 131 (2001), 10-20.
15. J.A. Glomset, G. Assmann, K.R. Gjone and K.R. Norum, Lechithin- cholesterol acyltransferase deficiency and fish eye disease, in: The Metabolic and Molecular Basis of Inherited Disease, C.R. Sciver, A.L. Beaudet, W.S. Sly and D. Valle, eds, McGraw-Hill, Health Profession Division, 1995, pp. 1933-1952.
16. L.M. Gordon and P.W. Mobley, Membrane lipids, membrane fluidity and enzyme activity, in: Membrane Fluidity in Biology, L.M. Gordon, ed., Academic Press, New York, 1985, pp. 1-49.
17. D.J. Hanahan and J.E. Ekholm, The expression of optimum ATPase activities in human erythrocytes: a comparison of different lytic procedures, Arch. Biochem. Biophys. 187 (1978), 170-179.
18. M.R. Hardeman, P.T. Goedhart, J.G.G. Dobbe and K.P. Lettinga, Laser-assisted optical rotational cell analyzer (LORCA). 1. A new instrument for measurement of various structural hemorheological parameters, Clin. Hemorheol. 14 (1994), 605-618.
19. G.J. Heider and R.L. Boyett, The picomole determination of free and total cholesterol in cells in culture, J. Lipid. Res. 19 (1978), 514-518.
20. R.M. Hochmuth and R.E. Waugh, Erythrocyte membrane elasticity and viscosity, Ann. Rev. Physiol. 49 (1987), 209-219.
21. +-ATPase and membrane and serum lipid profiles as related to alcohol, body mass index and blood pressure, Clin. Exp. Hypertens. 16 (1994), 741-759.
22. B.R. Krause and R.S. Newton, Animal models for the evaluation of inhibitors of HMG-CoA reductase, Adv. Lipid. Res. 1 (1991), 57-72.
23. M.R. Law and N.J. Wald, Risk factor threshold: their existence under scrutiny, Br. Med. J. 324 (2002), 1570-1576.
24. P. Lijnen, H. Celis, R. Fagard, J. Staessen and A. Amery, Influence of cholesterol lowering on plasma membrane lipids and cationic transport systems, J. Hypertension 12 (1994), 59-64.
25. P. Lijnen, R. Fagard, J. Staessen, L. Thijs and A. Amery, Erythrocyte membrane lipids and cationic transport systems in men, J. Hypertension 10 (1992), 1205-1211.
26. O.H. Lowry, A. Rosebrough, L. Farr and R.J. Randall, Protein measurement with the folin phenol reagent, J. Biol. Chem. 193 (1951), 265-272.
27. K. Maeda, K. Yasunari, E.F. Sato and M. Inoue, Enhanced oxidative stress in neutrophils from hyperlipidemic guinea pig, Atherosclerosis 181 (2005), 87-92.
28. N. Mohandas, J.A. Chasis and S.B. Shohet, The influence of membrane skeleton on red cell deformability, membrane material properties, and shape, Semin. Hematol. 20 (1983), 225-242.
29. N. Mohandas and E.A. Evans, Mechanical properties of the red cell membrane in relation to molecular structure and genetic defects, Annu. Rev. Biophys. Biomol. Struct. 23 (1994), 787-818.
30. J.S. Owen, Plasma lipoproteins and cellular metabolism, Nature 292 (1981), 106.
31. P.J. Quinn, The fluidity of cell membranes and its regulation, Prog. Biophys. Mol. Biol. 38 (1981), 1-104.
32. H.E. Rose and M. Oklander, Improved procedure for extraction of lipids from human erythrocytes, J. Lipid. Res. 6 (1965), 428-431.
33. M. Shinitzky, Membrane fluidity and cellular functions, in: Physiology of Membrane Fluidity, M. Shinitzky, ed., CRC Press, Boca Raton, FL, 1984, pp. 1-51.
34. A.R. Tall, Plasma cholesteryl ester transfer protein, J. Lipid. Res. 34 (1993), 1255-1274.
35. A. Tonkin, P. Aylward, D. Colquhoun, P. Glasziou, P. Harris, S. MacMahon, P. Magnus, D. Newel, P. Nestel, N. Sharpe, D. Hunt, J. Shaw, R.J. Simes, P. Thompson, A. Thomson, M. West, H. White, S. Simes, W. Hague, S. Caleo, J. Hall, A. Martin, S. Mulray, P. Barter, L. Beilin, R. Collins, J. McNeil, P. Meier, H. Willimott, D. Smithers, P. Wallace, D. Sullivan and A. Keech, Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels, New Eng. J. Med. 339 (1998), 1349-1357.
36. Y. Yawata, K. Miyashima, T. Sugihara, N. Murayama, S. Hosoda, S. Nakashima, H. Iida and Y. Nozawa, Self-adaptive modification of red cell membrane lipids in lecithin cholesterol acyl transferase deficiency. Lipid analysis and spin labeling, Biochim. Biophys. Acta 769 (1984), 440-448.